INTENSE PULSED LIGHT (IPL) TREATMENT FOR DUPILUMAB INDUCED OCULAR SURFACE DISEASE (DIOSD) | Zendy

Sathi Maiti | Zendy; Laura M. Periman | Zendy; Natasha Balani | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

INTENSE PULSED LIGHT (IPL) TREATMENT FOR DUPILUMAB INDUCED OCULAR SURFACE DISEASE (DIOSD)

Author(s) -

Sathi Maiti,

Laura M. Periman,

Natasha Balani

Publication year - 2022

Publication title -

journal of dry eye disease

Language(s) - English

Resource type - Journals

ISSN - 2561-9195

DOI - 10.22374/jded.v5i1.40

Subject(s) - dupilumab , medicine , intense pulsed light , adjunct , dermatology , atopic dermatitis , philosophy , linguistics

PurposeTo report a case of dupilumab induced ocular surface disease (DIOSD) managed with intense pulsed light (IPL) as an effective adjunct therapy to topical steroids and topical immunomodulator lifitegrast.MethodsDiscussion of a patient’s case with accompanying anterior segment and meibography photos with diagnosed DIOSD for which adjunct therapy with IPL was an effective treatment after limited relief from and difficulty with adherence to traditional treatment with topical steroids and lifitegrast ophthalmic solutions. ConclusionThis case demonstrates the complexity of management required to treat patients with DIOSD and its chronic nature. IPL as a nonpharmaceutical adjunct therapy to topical steroids and immunomodulators in the treatment of DIOSD showed improved signs and symptoms of DIOSD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research